BMEA vs CME · $94.7M cap vs P/E 22, rev $6.52B
Biomea Fusion Inc (BMEA) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
Biomea Fusion Inc (BMEA) is a biotechnology company listed on US.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
BMEA does not have a complete income-statement cache yet.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
BMEA currently screens at market cap $94.7M. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the BMEA and CME stock pages for the full models.
Not investment advice.